Terms: = Bone cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Prognosis
8 results:
1. Oral cancer in the Indian Subcontinent-Survival Outcomes and Risk Factors with Primary Surgery.
Thakar A; Thakur R; Kakkar A; Malhotra RK; Singh CA; Sikka K; Kumar R; Pramanik R; Biswas A; Bhalla AS; Bhaskar S; Sharma A
Laryngoscope; 2021 Oct; 131(10):2254-2261. PubMed ID: 33797083
[TBL] [Abstract] [Full Text] [Related]
2. [Comprehensive analysis of genomic detection for a patient with myelodysplastic syndrome].
Luo JX; Ai C; Huang YS; Wang HW; Hu CM; Zhao WW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1501-6. PubMed ID: 24370037
[TBL] [Abstract] [Full Text] [Related]
3. Apurinic/apyrimidinic endonuclease 1 induced upregulation of fibroblast growth factor 2 and its receptor 3 induces angiogenesis in human osteosarcoma cells.
Ren T; Qing Y; Dai N; Li M; Qian C; Yang Y; Cheng Y; Li Z; Zhang S; Zhong Z; Wang D
Cancer Sci; 2014 Feb; 105(2):186-94. PubMed ID: 24329908
[TBL] [Abstract] [Full Text] [Related]
4. Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
Bisping G; Wenning D; Kropff M; Gustavus D; Müller-Tidow C; Stelljes M; Munzert G; Hilberg F; Roth GJ; Stefanic M; Volpert S; Mesters RM; Berdel WE; Kienast J
Clin Cancer Res; 2009 Jan; 15(2):520-31. PubMed ID: 19147757
[TBL] [Abstract] [Full Text] [Related]
5. Early genetic events provide the basis for a clinical classification of multiple myeloma.
Kuehl WM; Bergsagel PL
Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
[TBL] [Abstract] [Full Text] [Related]
6. Molecular pathogenesis and a consequent classification of multiple myeloma.
Bergsagel PL; Kuehl WM
J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
[TBL] [Abstract] [Full Text] [Related]
7. Advances in biology of multiple myeloma: clinical applications.
Hideshima T; Bergsagel PL; Kuehl WM; Anderson KC
Blood; 2004 Aug; 104(3):607-18. PubMed ID: 15090448
[TBL] [Abstract] [Full Text] [Related]
8. Fibroblast growth factor receptor 3 (fgfr3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas.
Dai H; Holm R; Kristensen GB; Abeler VM; Børresen-Dale AL; Helland A
Anal Cell Pathol; 2001; 23(2):45-9. PubMed ID: 11904459
[TBL] [Abstract] [Full Text] [Related]
